Thus, the relative cellular immune response after routine vaccination at 15 months of age as measured by IFN-γ ELISpot analyses was significantly lower in the MMR intervention group compared to the placebo intervention group reflecting the ability of vaccine-induced pre-existing immunity to effectively contain a new vaccine-induced measles challenge. The gene discussed is IFNG; the disease is measles.